Suppr超能文献

通过剖腹术获取胰腺同种异体移植活检组织。

Availability of pancreatic allograft biopsies via a laparotomy.

作者信息

Kitada H, Sugitani A, Okabe Y, Doi A, Nishiki T, Miura Y, Kurihara K, Tanaka M

机构信息

Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan.

出版信息

Transplant Proc. 2009 Dec;41(10):4274-6. doi: 10.1016/j.transproceed.2009.09.066.

Abstract

OBJECTIVE

The aim of this study was to evaluate the availability of a pancreatic allograft biopsy via a laparotpmy.

PATIENTS AND METHODS

From September 2004 to November 2007, 17 pancreas transplantations were performed: 15 simultaneous pancreas and kidney transplantations (SPK), 1 pancreas transplant alone (PTA), and one pancreas after kidney transplantation (PAK). Thirteen pancreatic allograft biopsies were obtained via an open laparotomy. This study evaluated the complications associated with this procedure, the rate of obtaining an adequate sample, and the relationship between biopsy-proven rejections and laboratory markers. In SPK cases we evaluated the synchronization between pancreas and kidney rejection. The pancreatic samples were diagnosed according to the Drachenberg classification.

RESULTS

No complications resulted from the procedure. The rate of obtaining adequate samples was 84.6%. Pancreas rejection correlated with elevation of the laboratory markers in 71.4%. Simultaneous pancreas and kidney rejection occurred in 62.5%, only kidney in 25%, and only pancreas in 12.5%.

CONCLUSION

A pancreas graft biopsy was absolutely imperative to improve the outcome in PTA, and even in SPK cases. A pancreatic allograft biopsy via a laparotomy was a safe, necessary and easy procedure to obtain an accurate diagnosis of rejection among pancreas transplantation patients.

摘要

目的

本研究旨在评估经剖腹术获取胰腺移植活检组织的可行性。

患者与方法

2004年9月至2007年11月,共进行了17例胰腺移植手术:15例胰肾联合移植(SPK)、1例单纯胰腺移植(PTA)以及1例肾移植后胰腺移植(PAK)。通过开放性剖腹术获取了13份胰腺移植活检组织。本研究评估了该操作相关的并发症、获取足够样本的比例以及活检证实的排斥反应与实验室指标之间的关系。在SPK病例中,我们评估了胰腺和肾脏排斥反应的同步性。胰腺样本根据德拉亨伯格分类法进行诊断。

结果

该操作未引发并发症。获取足够样本的比例为84.6%。71.4%的病例中胰腺排斥反应与实验室指标升高相关。胰肾同时发生排斥反应的占62.5%,仅肾脏发生排斥反应的占25%,仅胰腺发生排斥反应的占12.5%。

结论

对于改善PTA甚至SPK病例的预后,胰腺移植活检绝对必要。经剖腹术进行胰腺移植活检是一种安全、必要且简便的操作,能够准确诊断胰腺移植患者的排斥反应。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验